Summary
NVIDIA Corporation announced a significant change to its Board of Directors with the appointment of Dr. Ellen Ochoa, effective November 7, 2024. This appointment increases the size of the Board from twelve to thirteen members. Dr. Ochoa, a former astronaut and distinguished figure in STEM, is expected to contribute valuable expertise to NVIDIA's governance. Her addition signals a potential enhancement in the company's strategic oversight and corporate governance practices. In connection with her appointment, Dr. Ochoa will receive initial equity grants, including restricted stock units vesting over three years and a pro-rated annual grant vesting in May 2025, along with a pro-rated annual cash retainer. These compensation arrangements are standard for new board members and are designed to align her interests with those of the company and its shareholders. Investors should note this expansion of the board as a step towards potentially broadening the diverse perspectives and experiences guiding NVIDIA's future.
Key Highlights
- 1NVIDIA appointed Dr. Ellen Ochoa to its Board of Directors, effective November 7, 2024.
- 2The Board size has been increased from twelve to thirteen directors.
- 3Dr. Ochoa is expected to be appointed to the Nominating and Corporate Governance Committee.
- 4Dr. Ochoa will receive an initial equity grant of 1,848 restricted stock units vesting over three years.
- 5A pro-rated annual equity grant of 1,321 restricted stock units will vest on May 21, 2025.
- 6She was granted a pro-rated annual cash retainer of $53,800, payable starting November 7, 2024.
- 7An indemnity agreement has been entered into with Dr. Ochoa.